LAUSR

References 1 Fusco F, Paciolla M, Conte MI, et al. Incontinentia pigmenti: report on data from 2000 to 2013. Orphanet J Rare Dis 2014; 9:93. 2 Smahi A, Courtois G, Vabres P, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 2000; 405:466–472. 3 Buinauskaite E, Buinauskiene J, Kucinskiene V, et al. Incontinentia pigmenti in a male infant with Klinefelter syndrome: a case report and review of the literature. Pediatr Dermatol 2010; 27:492–495. 4 Swinney CC, Han DP, Karth PA. Incontinentia pigmenti: a comprehensive review and update. Ophthalmic Surg Lasers Imaging Retina 2015; 46:650–657. 5 Minic S, Obradovic M, Kovacevic I, et al. Ocular anomalies in incontinentia pigmenti: literature review and meta-analysis. Srp Arh Celok Lek 2010; 138:408–413. 6 Minic S, Trpinac D, Gabriel H, et al. Dental and oral anomalies in incontinentia pigmenti: a systematic review. Clin Oral Investig 2013; 17:1–8. 7 Minic S, Trpinac D, Obradovic M. Systematic review of central nervous system anomalies in incontinentia pigmenti. Orphanet J Rare Dis 2013; 8:25. 8 Wolf DS, Golden WC, Hoover-Fong J, et al. High-dose glucocorticoid therapy in the management of seizures in neonatal incontinentia pigmenti: a case report. J Child Neurol 2015; 30:100–106. 9 Onnis G, Diociaiuti A, Zangari P, et al. Cardiopulmonary anomalies in incontinentia pigmenti patients. Int J Dermatol 2018; 57:40–45. 10 Yasuda K, Minami N, Yoshikawa Y, et al. Fatal pulmonary arterial hypertension in an infant girl with incontinentia pigmenti. Pediatr Int 2016; 58:394–396. 11 Atallah V, Meot M, Kossorotoff M, et al. A case of reversible pulmonary arterial hypertension associated with incontinentia pigmenti. Pulm Circ 2018; 8:2045894018793983. 12 Pilkington SA, Taboada D, Martinez G. Pulmonary hypertension and its management in patients undergoing noncardiac surgery. Anaesthesia 2015; 70:56–70.